Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cancer of Prostate

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Cancer of Prostate in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (86.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Appelhans, D; Boye, S; Daeg, J; Janke, A; Lederer, A; Shi, X; Temme, A; Voit, B; Xu, X; Zhao, J; Zhao, L1
Hong, Y; Kim, DY; Min, JJ; Pyo, A; Sik Kim, H; You, SH; Young Kim, J1
Andersson, KG; Löfblom, J; Mitran, B; Orlova, A; Rinne, SS; Rosestedt, M; Ståhl, S; Tolmachev, V1
Chen, X; Cheng, S; Gu, D; Jacobson, O; Lang, L; Ma, Y; Niu, G; Wang, Z; Yung, B; Zhu, G; Zhu, X1
Balasse, L; Bouhlel, A; Ding, L; Fernandez, S; Garrigue, P; Giorgio, S; Guillet, B; Huang, Y; Iovanna, J; Lan, W; Laurini, E; Liu, X; Lyu, Z; Marson, D; Mas, E; Peng, L; Pricl, S; Tang, J; Tintaru, A; Weng, Y; Zhang, M1
Cheng, Z; Kjaer, A; Liu, H; Madsen, J; Persson, M1
Aberg, O; Antoni, G; Larhed, M; Lindeberg, G; Orlova, A; Sandström, M; Sörensen, J; Tolmachev, V; Varasteh, Z; Velikyan, I1
Bandari, RP; Durkan, K; Hoffman, TJ; Jiang, Z; Liu, L; Miao, Y; Reynolds, TS; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF1
Chen, F; Luo, S; Pan, D; Wang, L; Xu, YP; Yan, Y; Yang, M; Yang, RH1
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G1
Kjaer, A; Persson, M; Skovgaard, D1
Ashino, H; Dozono, H; Hino, A; Kasahara, H; Minamizawa, T; Oshikiri, S; Satake, M; Suwada, J; Suzuki, K1
Bottenus, BN; Hoffman, TJ; Nanda, PK; Pandey, U; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF1
Altai, M; Braun, A; Garske, U; Karlström, AE; Malmberg, J; Orlova, A; Perols, A; Sandström, M; Tolmachev, V; Varasteh, Z1
Ait-Mohand, S; Bénard, F; Dumulon-Perreault, V; Fournier, P; Guérin, B; Lecomte, R; Tremblay, S1

Reviews

1 review(s) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cancer of Prostate

ArticleYear
Imaging of Prostate Cancer Using Urokinase-Type Plasminogen Activator Receptor PET.
    PET clinics, 2017, Volume: 12, Issue:2

    Topics: Animals; Drug Evaluation, Preclinical; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Urokinase Plasminogen Activator; Tomography, X-Ray Computed

2017

Other Studies

14 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cancer of Prostate

ArticleYear
Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine.
    Biomacromolecules, 2020, 01-13, Volume: 21, Issue:1

    Topics: Animals; Antigens, Surface; Avidin; Biotin; Chelating Agents; Contrast Media; Dendrimers; Diagnostic Imaging; ErbB Receptors; Folic Acid; Glutamate Carboxypeptidase II; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanomedicine; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2020
Production of
    Bioorganic & medicinal chemistry letters, 2020, 07-15, Volume: 30, Issue:14

    Topics: Animals; Antibodies; Copper Radioisotopes; Ephrin-A2; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Molecular Structure; Neoplasms, Experimental; PC-3 Cells; Positron-Emission Tomography; Prostatic Neoplasms; Receptor, EphA2

2020
Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression.
    International journal of oncology, 2017, Volume: 51, Issue:6

    Topics: Animals; Cell Line, Tumor; Cobalt Radioisotopes; Colorectal Neoplasms; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Male; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Prostatic Neoplasms; Radioligand Assay; Radiopharmaceuticals; Receptor, ErbB-3

2017
Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN
    Bioconjugate chemistry, 2018, 02-21, Volume: 29, Issue:2

    Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Female; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Inbred BALB C; Peptides; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Receptors, Bombesin

2018
Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 11-06, Volume: 115, Issue:45

    Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Coordination Complexes; Dendrimers; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms

2018
First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorine Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Ligands; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiochemistry; Receptors, Urokinase Plasminogen Activator

2013
In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Amino Acid Sequence; Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Ethylene Glycols; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, Bombesin

2013
A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:2

    Topics: Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Dimerization; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Receptors, Bombesin

2014
A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Amino acids, 2014, Volume: 46, Issue:6

    Topics: Animals; Bombesin; Cell Line, Tumor; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Isotope Labeling; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, Bombesin; Tissue Distribution

2014
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Nuclear medicine communications, 2015, Volume: 36, Issue:9

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed

2015
Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:7

    Topics: Animals; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Chelating Agents; Diphosphonates; Durapatite; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Osteolysis; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Reproducibility of Results

2011
Bombesin analogues for gastrin-releasing peptide receptor imaging.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:4

    Topics: Animals; Binding, Competitive; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Molecular Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Protein Transport; Receptors, Bombesin; X-Ray Microtomography

2012
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:3

    Topics: Acetates; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Male; Mice; Molecular Imaging; Molecular Sequence Data; Prostatic Neoplasms; Receptor, ErbB-2; Substrate Specificity

2012
Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
    Bioconjugate chemistry, 2012, Aug-15, Volume: 23, Issue:8

    Topics: Animals; Bombesin; Breast Neoplasms; Copper Radioisotopes; Drug Stability; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Male; Mice; Polyethylene Glycols; Positron-Emission Tomography; Prostatic Neoplasms; Protein Transport

2012